Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,551 | -8,805 | 18,143 | 3,141 | -2,479 |
| Depreciation Amortization | 8,372 | 4,163 | 11,197 | 7,679 | 4,909 |
| Income taxes - deferred | -135 | -4,516 | 3,383 | 8,679 | 4,080 |
| Accounts receivable | 41,674 | 33,079 | -21,890 | 57,006 | 27,338 |
| Accounts payable and accrued liabilities | -6,199 | -4,196 | 274 | -3,495 | -7,068 |
| Other Working Capital | 14,810 | 2,968 | -12,832 | 42,509 | 11,378 |
| Other Operating Activity | -31,871 | -27,319 | 41,368 | -36,857 | -5,980 |
| Operating Cash Flow | $28,202 | $-4,626 | $39,643 | $78,662 | $32,178 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,966 | 1,966 | 1,966 |
| PPE Investments | -14,123 | -7,679 | -42,080 | -29,178 | -19,156 |
| Investing Cash Flow | $-14,123 | $-7,679 | $-40,114 | $-27,212 | $-17,190 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 13,547 | 12,946 | 11,413 |
| Debt Repayment | -2,235 | -1,117 | -10,227 | -9,386 | -8,670 |
| Common Stock Issued | 933 | 504 | 761 | 495 | 401 |
| Common Stock Repurchased | N/A | N/A | -5,906 | -1,457 | N/A |
| Other Financing Activity | 1,757 | 1,608 | 60 | -46 | -221 |
| Financing Cash Flow | $455 | $995 | $-1,765 | $2,552 | $2,923 |
| Exchange Rate Effect | 43 | -118 | 1 | -2 | 31 |
| Beginning Cash Position | 141,666 | 141,666 | 143,901 | 143,901 | 143,901 |
| End Cash Position | 156,243 | 130,238 | 141,666 | 197,901 | 161,843 |
| Net Cash Flow | $14,577 | $-11,428 | $-2,235 | $54,000 | $17,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,202 | -4,626 | 39,643 | 78,662 | 32,178 |
| Capital Expenditure | -14,123 | -7,679 | -53,845 | -40,943 | -30,921 |
| Free Cash Flow | 14,079 | -12,305 | -14,202 | 37,719 | 1,257 |